Biomarkers in Down syndrome can help us understand Alzheimer's disease

Affiliations

¹ Department of Pathology and Laboratory Medicine, University of California, Irvine, CA 92697, USA. Electronic address: heade@uci.edu.
² Department of Neurology, Washington University, St Louis, MO, USA.

Comment

Elizabeth Head et al. Lancet. 2020.

. 2020 Jun 27;395(10242):1951-1953.

doi: 10.1016/S0140-6736(20)30916-8.

¹ Department of Pathology and Laboratory Medicine, University of California, Irvine, CA 92697, USA. Electronic address: heade@uci.edu.
² Department of Neurology, Washington University, St Louis, MO, USA.

No abstract available

Comment on

Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
Fortea J, Vilaplana E, Carmona-Iragui M, Benejam B, Videla L, Barroeta I, Fernández S, Altuna M, Pegueroles J, Montal V, Valldeneu S, Giménez S, González-Ortiz S, Muñoz L, Estellés T, Illán-Gala I, Belbin O, Camacho V, Wilson LR, Annus T, Osorio RS, Videla S, Lehmann S, Holland AJ, Alcolea D, Clarimón J, Zaman SH, Blesa R, Lleó A. Fortea J, et al. Lancet. 2020 Jun 27;395(10242):1988-1997. doi: 10.1016/S0140-6736(20)30689-9. Lancet. 2020. PMID: 32593336 Free PMC article.